Abstract Atropine is the mainstay of therapy in organophosphate (OP) toxicity, though research and consensus on dosing is lacking. In 2004, as reported by Eddleston et al. (J Toxicol Clin Toxicol 42(6):865-75, 2004), they noted variation in recommended regimens. We assessed revisions of original references, additional citations, and electronic sources to determine the current variability in atropine dosing recommendations. Updated editions of references from Eddleston et al.'s work, texts of Internal and Emergency Medicine, and electronic resources were reviewed for atropine dosing recommendations. For comparison, recommendations were assessed using the same mean dose (23.4 mg) and the highest dose (75 mg) of atropine as used in the original paper. Recommendations were also compared with the dosing regimen from the World Health Organization (WHO). Thirteen of the original recommendations were updated and 15 additional references were added giving a convenience sample of 28. Sufficient information to calculate time to targeted dose was provided by 24 of these samples. 
Introduction
Organophosphate (OP) toxicity remains a major public health concern, primarily in the developing world, where widespread availability of agricultural pesticides may account for 200,000 deaths every year [1] . Although atropine is clearly the mainstay of initial therapy, strong consensus on the proper dosing regimen of atropine in OP-poisoned patients is lacking, likely due to the limited evidence on the optimal atropine dosing strategy. In 2004, Eddleston et al. assessed atropine dosing regimens from international authoritative texts [2] . The authors noted the mean atropine loading dose was 23.4 mg to treat cholinergic symptoms in a cohort of 22 Sri Lankan patients following intentional OP ingestions requiring intubation. They also noted the maximal initial dose, 75 mg, required by one patient. Referencing international authoritative texts, the authors found significant variation in recommended dosing regimens leading to huge variations in the time until the mean and maximal required atropine dose could be administered. In this analysis, the World Health Organization (WHO)'s recommendations resulted in the slowest rates of atropinization. The authors called on the medical community to evaluate the benefits of rapid atropine dosing and come to a consensus that could be easily followed by those treating OP-poisoned Electronic supplementary material The online version of this article (doi:10.1007/s13181-013-0324-9) contains supplementary material, which is available to authorized users.
patients. Almost a decade after this important work was published, the sources that physicians are using have changed from large tomes to internet resources and medical applications accessed via smartphone. Our aim was to evaluate the current references with regard to initial atropine dosing recommendations to determine if the variability described by Eddleston et al. persists and to see how newer electronic resources compare to standard reference texts. Additionally, we aimed to compare these references to the WHO's guidelines which may be the most accessible to those clinicians working in regions where OP poisoning is common.
Methods
Recommendations for atropine dosing in acute OP-poisoned patients were sought from updated and revised editions of the sources from Eddleston et al.'s original paper and additional resources that were not included in that study (see Supplementary  Table for list of texts). Major texts of Internal and Emergency Medicine and Toxicology (Cecil [3] , Tintinalli [4] , Rosen [5] , Goodman and Gilman [6] , Casarett [7] , Wexler [8] ) were added to the source list as were medical study and pocket guides (Tarascon [9] , Rivers [10] , Wyatt [11] , Stone [12] ). Additionally, new electronic resources such as UpToDate [13] , eMedicine [14] , Lexicomp [15] , Access Medicine [16] , and Epocrates [17] were accessed for this analysis since these internet sources can be easily used at the bedside via physicians' mobile devices or from a nearby desktop and have the potential to significantly impact medical care. Recommended dosing regimens for initial atropine administration in acute OP poisoning were recorded from each text.
Statistical Analysis
Dosing recommendations were applied to two hypothetical patients using the mean required loading dose, 23.4 mg, used for the Sri Lankan patients in Eddleston et al.'s original paper and to the highest utilized loading dose, 75 mg in their cohort. The time until adequate dosing for these two scenarios was then calculated for each text's recommendation and these times were compared. 
Results
We were unable to locate six sources from Eddleston et al.'s article and 24 of the original sources had not been updated since 2004 (see Supplementary Table) . Thirteen of the sources from Eddleston et al.'s publication had updated recommendations and 15 additional sources were added giving a convenience sample of 28 recommendations . Of the reviewed references, Tintinalli [4] , Casarett [7] , and Wexler [8] were too vague to allow calculation of time until adequate atropine dose and eMedicine [14] gave a recommendation for dosing that would never reach the mean or maximum atropine doses for patients with severe OP poisoning. The remaining 24 sources provided enough information to make comparisons between times until administration of our targeted loading doses. Five recommendations (Cecil [3] , Rivers [10] , Wyatt [11] , the British National Formulary [25] , and Leikin [28] ) provided an exact dosing regimen whereas all others provided a range. In several sources, the maximum time that would be required to administer the mean atropine dose based on current recommendations and those reported in 2004 have changed significantly. ToxiNZ [20] has the largest improvement with a decrease of 11.2 h. WHO [26] and Haddad [22] had decreases of over 5 h. Wikitox [23] and Olson [19] suggest regimens that result in improvements of at least 3.5 h compared to 2004. The minimal time until administration of 23.4 mg is unchanged from prior in the current British National Formulary [25] regimen, but the maximal time to reach that same goal decreased by 55 min as the recommended dosing interval was changed from every 5-10 min, to simply every 5 min in the current iteration. Krieger [27] and Leikin [28] updated their recommendations to regimens that achieve the 23.4-mg goal dose more slowly, by 25 and 115 min, respectively. Notably, the WHO [26] recommendation, which was among the slowest in 2004, remains in the slowest 20 % in the current analysis.
Discussion
In areas where OP toxicity is a major health concern, delay to atropinization can be fatal due to central nervous system effects, bradycardia, circulatory collapse, and respiratory failure from bronchorrhea and bronchospasm. The aggressive treatment of patients with increasing doses of atropine at frequent intervals has the potential to significantly reduce the morbidity from OP poisoning. Eddleston et al.'s work in 2004 shed light on the significant differences in atropine dosing recommendations. Although there is little evidence proving that rapid atropinization is beneficial, animal data suggests early death after OP toxicity is, at least in part, centrally mediated. Mortality in mice is mitigated by pretreatment with anticholinergics that cross the blood brain barrier [31] . Additionally, there is observational evidence suggesting that rapid atropinization with dose doubling every 3 to 5 min is protective against mental status changes and decreases the case fatality rate of severe OP ingestions. Interestingly, in the cohort of patients that received titrated atropine rather than ad hoc administration, the patients were more critically ill and lower cumulative doses of atropine were given, causing fewer cases of atropine toxicity [32] . While the ideal randomized controlled trial evaluating the benefits of rapid atropinization in severely OP-poisoned patients has not been performed, atropine is able to prevent central symptoms and lessen bronchorrhea and bronchoconstriction characteristic of OP toxicity. It is reasonable to conclude that allowing these symptoms to continue for hours longer than necessary could pose significant risks for patient harm.
A consensus on the correct atropine dosing regimen does not exist. However there has been a shift in just a few years towards achieving atropinization much faster as many authoritative texts and new online sources suggest doubling the last dose when a patient requires further atropine treatment. Regimens that include dose doubling result in significant dose escalation and even allow a patient with a higher atropine requirement to be treated in less than 1 h. This is a significant improvement over the previously recommended regimens. Interestingly, Lexicomp [15] , Access Medicine [16] , and UpToDate [13] , all online resources, suggest dosing schemes that allow for the fastest titration of atropine. While it is unreasonable to think that every hospital can easily access these sites, there is an undeniable trend toward greater reliance on internet resources for medical information and these sources can be utilized by a very broad audience. Like the other updated guidelines, the WHO [26] recommendation is an improvement on prior iterations, but still lags significantly behind many other sources. This is unfortunate as the WHO recommendation may be the most widely accessed throughout the regions of the world where OP toxicity remains an important concern.
Limitations: This review is a convenience sample of sources that the authors were able to access and included some of the most widely used texts and references. Limitations based on institutional subscriptions and availability prevented this analysis from being a complete review of published guidelines. It is also important to realize that while there is an assumption that rapid atropinization improves outcome, this has not been substantiated. The only "outcome" evaluated here is the time to atropinization rather than a clinical benefit.
Conclusion
In 2004, there was a call for clinical toxicology associations to work with the WHO to produce a simple and evidence-based guideline for the treatment of severe OP poisoning that could be disseminated worldwide. While the WHO recommendation lags in terms of the time to appropriate dosing for an average patient with severe OP poisoning and even more significantly, for those in the reference cohort with the highest atropine requirements, other authors have come closer to a consensus and their recommendations can treat severely poisoned patients within 1 h. We urge both further patientcentered research and efforts at consensus building pending the results of clinical trials.
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